Hebron Technology Co., Ltd. Exhibited at ACHEMA

Monday, June 18, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

WENZHOU, China, June 18, 2018 /PRNewswire/ -- Hebron Technology Co., Ltd. ("Hebron" or the "Company") (Nasdaq: HEBT), a developer,

manufacturer and installer of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and other clean industries , today announced its participation in the ACHEMA Frankfurt 2018 International Exhibition-Congress ("ACHEMA")
held at the Frankfurt Convention and Exhibition Center in Germany from June 11-15, 2018.

ACHEMA, held every 3 years, is an internationally renowned conference focused on chemical engineering, process engineering and biotechnology. The 2018 event attracted 3,737 exhibition stands from across the world. The expo promotes exchange and cooperation between manufacturers and users in the chemical, pharmaceutical, and food industries worldwide, and showcases innovative technologies and development in the industry. 

Hebron exhibited its comprehensive technical services and competitive product lines at ACHEMA. Hebron participated in the event to open overseas international trade markets, exchange advanced technologies and product services in the pharmaceutical industry, and promote the internationalization of the Hebron brand, products, and technology.

Mr. Anyuan Sun, Chairman and Chief Executive Office of Hebron, commented, "We are pleased with the reception our exhibition received from companies across the world as we developed the foundations for future cooperation. ACHEMA also gave us the chance to reconnect with old clients to lay the groundwork for future growth and collaboration."

About Hebron Technology Co., Ltd.

Established in January 2005 and headquartered in Wenzhou City, Zhejiang Province, China, Hebron Technology Co., Ltd. ("Hebron" or the "Company") engages in research, development, and manufacture of highly specialized valves and pipe fitting products for use in the pharmaceutical, biological, food and beverage, and other clean industries. The Company also offers its customers comprehensive pipeline design, installation, construction, and ongoing maintenance services as holistic solution services. For more information about the Company, please visit www.xibolun.com.

Forward-Looking Statements

This press release contains information about Hebron's view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. Hebron encourages you to review other factors that may affect its future results in Hebron's registration statement and in its other filings with the Securities and Exchange Commission.

For more information, please contact:

In China:

Hebron Technology Co., Ltd.  Ms. Yingping Chen SecretaryPhone: +86-180-6776-3129

In the United States:

Ascent Investor Relations LLC Ms. Tina XiaoPhone: +1-917-609-0333Email: tina.xiao@ascent-ir.com

Cision View original content:http://www.prnewswire.com/news-releases/hebron-technology-co-ltd-exhibited-at-achema-300667017.html

SOURCE Hebron Technology Co., Ltd.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store